Oriele Sarno
Contrada, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The impact of apremilast on cardiometabolic and inflammation indexes in psoriatic patients at high cardiovascular risk: A real-world multicenter retrospective observational study.
Journal: Journal of the American Academy of Dermatology
Published: October 06, 2025
Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study.
Journal: Clinical and experimental dermatology
Published: July 01, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.
Journal: International journal of dermatology
Published: May 21, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis).
Journal: Dermatology practical & conceptual
Published: March 06, 2025
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study - IL PSO (Italian Landscape Psoriasis).
Journal: The Journal of dermatological treatment
Published: February 06, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: January 17, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).
Journal: Journal of clinical medicine
Published: December 31, 2024
A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?
Journal: Dermatology practical & conceptual
Published: September 25, 2024
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study.
Journal: Journal of clinical medicine
Published: March 25, 2024
Treatment of a relapsing facial pyoderma gangrenosum (malignant pyoderma).
Journal: International journal of dermatology
Published: January 22, 2013
Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline.
Journal: European journal of dermatology : EJD
Published: September 29, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026